ALKternate: A Proof of Concept Study in ALK-Rearranged NSCLC Alternating Lorlatinib With Crizotinib After Disease Progression

被引：0
|
作者：
Itchins, M. [1 ]
Liang, S. [1 ]
Brown, C. [2 ]
Solomon, B. [3 ]
Pavlakis, N. [1 ]
机构：
[1] Royal North Shore Hosp, Med Oncol, St Leonards, NSW, Australia
[2] Univ Sydney, Nhmrc Clin Trials Ctr, Camperdown, NSW, Australia
[3] Peter Maccallum Canc Ctr, Melbourne, Vic, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
Drug resistance; ALK; Clinical trial;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P47.12
引用
收藏
页码：S1101 / S1102
页数：2
相关论文
共 50 条
  • [31] Symptomatic CNS Radiation Necrosis Requiring Neurosurgical Resection During Treatment with Lorlatinib in ALK-Rearranged NSCLC: A Report of Two Cases
    Zhu, Viola W.
    Nagasaka, Misako
    Kubota, Takafumi
    Raval, Kunil
    Robinette, Natasha
    Armas, Octavio
    Al-Holou, Wajd
    Ou, Sai-Hong Ignatius
    LUNG CANCER-TARGETS AND THERAPY, 2020, 11 : 13 - 18
  • [32] Lorlatinib in patients with ALK plus NSCLC treated beyond initial disease progression
    Ou, S. I.
    Solomon, B.
    Shaw, A.
    Gadgeel, S. M.
    Besse, B.
    Soo, R. A.
    Abbattista, A.
    Thurm, H.
    Toffalorio, F.
    Wiltshire, R. J.
    Bearz, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S842 - S842
  • [33] Clinical benefit of continuing crizotinib therapy after initial disease progression in Chinese patients with advanced ALK-rearranged non-small-cell lung cancer
    Hong, Xiangchan
    Chen, Qi
    Ding, Lingyu
    Liang, Ying
    Zhou, Ningning
    Fang, Wenfeng
    Chen, Xinru
    Wu, Haiying
    ONCOTARGET, 2017, 8 (25) : 41631 - 41640
  • [34] Deep RNA Sequencing Revealed Fusion Junctional Heterogeneity May Predict Crizotinib Treatment Efficacy in ALK-Rearranged NSCLC
    Song, Zhengbo
    Lian, Shifeng
    Mak, Silvia
    Chow, Maggie Zi-Ying
    Xu, Chunwei
    Wang, Wenxian
    Keung, Hoi Yee
    Lu, Chenyu
    Kebede, Firaol Tamiru
    Gao, Yanqiu
    Cheuk, Wah
    Cho, William Chi Shing
    Yang, Mengsu
    Zheng, Zongli
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (02) : 264 - 276
  • [35] Crizotinib-induced osteitis mimicking bone metastasis in a stage IV ALK-rearranged NSCLC patient: a case report
    F. Guisier
    N. Piton
    M. Bellefleur
    N. Delberghe
    G. Avenel
    E. Angot
    O. Vittecoq
    M. Ould-Slimane
    H. Morisse-Pradier
    M. Salaun
    L. Thiberville
    BMC Cancer, 20
  • [36] Local Treatment for Oligoprogression/ Oligometastases After Failure to Crizotinib for ALK-Rearranged Stage IV Lung Cancer
    Kam, T. Y.
    Li, J.
    Lim, M. Y.
    Chan, O. S. H.
    Cheung, K. C.
    Lee, V.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S685 - S685
  • [37] Pitfalls in Oncology: Osteoblastic Response Mimicking Bone Progression during Ceritinib Treatment in ALK-Rearranged NSCLC
    Gelsomino, Francesco
    Ambrosini, Valentina
    Melotti, Barbara
    Sperandi, Francesca
    Ardizzoni, Andrea
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (08) : E99 - E101
  • [38] Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: a case report
    Minari, Roberta
    Gnetti, Letizia
    Lagrasta, Costanza Annamaria
    Squadrilli, Anna
    Bordi, Paola
    Azzoni, Cinzia
    Bottarelli, Lorena
    Cosenza, Agnese
    Ferri, Leonarda
    Caruso, Giuseppe
    Silini, Enrico Maria
    Tiseo, Marcello
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (03) : 787 - 792
  • [39] Identification of a high-level MET amplification in CTCs and cfTNA in an ALK-rearranged NSCLC patient developing evasive resistance to crizotinib
    Berger, L. -A.
    Velthaus, J. -L.
    Janning, M.
    Schatz, S.
    Falk, M.
    Iglauer, P.
    Simon, R.
    Cao, R.
    Bramlett, K.
    Buson, G.
    Petrini, E.
    Forcato, C.
    Tiemann, M.
    Sauter, G.
    Bokemeyer, C.
    Reck, M.
    Riethdorf, S.
    Pantel, K.
    Wikman, H.
    Loges, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 296 - 297
  • [40] ALK-rearranged lung adenocarcinoma patient with development of severe sinus bradycardia after treatment with crizotinib: A case report
    Qiu, Ye
    Li, Bixun
    Zhang, Yihong
    Guo, Xiaoyun
    Xiang, Chunzhi
    Wang, Congshui
    Lu, Yang
    Ren, Shuang
    Zhao, Juan
    MEDICINE, 2019, 98 (11)
12345